RECRUITINGOBSERVATIONAL
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Long-Term Follow-Up of Subjects Treated With NTLA-2001
About This Trial
This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
Who May Be Eligible (Plain English)
Who May Qualify:
1. A subject has completed or discontinued from an Intellia-sponsored clinical study in which a complete or partial dose of NTLA-2001 was received.
2. A subject has provided willing to sign a consent form for the LTFU study.
Who Should NOT Join This Trial:
None
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. A subject has completed or discontinued from an Intellia-sponsored clinical study in which a complete or partial dose of NTLA-2001 was received.
2. A subject has provided informed consent for the LTFU study.
Exclusion Criteria:
None
Locations (4)
Clinical Trial Site
Paris, France
Clinical Trial Site
Auckland, New Zealand
Clinical Trial Site
Umeå, Sweden
Clinical Trial Site
London, United Kingdom